Clinical Trial Update: Difference of Basal Insulin Titration Method in Reducing HbA1c Among Type 2 Diabetes Mellitus (T2DM) Patients. [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing daily basal insulin titration versus three-times-daily titration to determine which regimen better reduces HbA1c with less hypoglycemi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Snippet

Sponsor: University of Malaya | Conditions: to Identify Which Titration Regimen of Basal Insulin (Being Daily Titration vs 3 Daily Titration) is Better in Reducing hba1c and Have Lesser Hypoglycemia | Phase 4 | Status: UNKNOWN